The Influence of Hydro-Alcoholic Media on Drug Release - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Influence of Hydro-Alcoholic Media on Drug Release
The authors investigate the influence of hydro-alcoholic media on hydration and drug release from polyethylene oxide extended-release matrices.


Pharmaceutical Technology
Volume 35, Issue 7, pp. 50-58

26. H.M. Fadda, M.A.M Mohamed, and A.W. Basit, Int. J. Pharm. 360 (1-2) 171–176 (2008).

27. M. Walden et al., Drug. Dev. Ind. Pharm. 33 (10) 1101–1111 (2007).

28. J. Koziara, J. So, and N. Agarwal, presentation at the AAPS Annual Meeting and Exposition (San Antonio, TX, 2006).

29. M. Roberts et al., Int. J. Pharm. 332 (1-2) 31–37 (2007).

30. M.J. Traynor et al., Drug. Dev. Ind. Pharm. 34 (8) 885–889 (2008).

31. S. Missaghi, K.A. Fegely, and A.R. Rajabi-Siahboomi, AAPS. PharmSci. 10 (1) 77–80 (2009).

32. B. Ager et al., presentation at the 36th Annual Meeting & Exposition of the Controlled Release Society (Copenhagen, Denmark, 2009).

33. J.E.F. Reynolds, K. Parfitt, A.V. Parsons, S.C. Sweetman, Eds., Martindale, The Extra Pharmacopoeia, 29th ed. (Pharmaceutical Press, London, UK, 1989).

34. A.C. Moffat, M.D. Osselton, and B. Widdop, Eds., Clarke's Analysis of Drugs and Poisons, Vol. 2 (Pharmaceutical Press, London, 2004).

35. N. Seedher, and M. Kanojia, Pharm. Dev. Technol. 14 (2) 185–192 (2009).

36. F.E. Bailey Jr. and J.V. Koleski, Poly(ethy1ene oxide), Chapter 5 (Academic Press, New York, 1976) p. 87.

37. Colorcon "HyperStart services," http://www.colorcon.com/ (2010).

38. FDA, "The Influence of Hydrophilic Pore Formers on Dipyridamole Release from Aqueous Ethylcellulose Film-Coated Pellets," Fed. Regist., 60 (230) p.61642 (1995).

39. P.L. Ritger, and N.A. Peppas, J. Control. Release. 5 (1) 23–36 (1987).

40. P.L. Ritger and N.A. Peppas, J. Control. Release. 5 (1) 37–42 (1987).

41. R. Espinoza, E. Hong, and L. Villafuerte, Int. J. Pharm. 201 (2) 165–173 (2000).

42. J.L. Ford et al., Int. J. Pharm. 71 (1-2) 95–104 (1991).

43. N.K. Ebube et al., Int. J. Pharm. 156 (1) 49–57 (1997).

44. N.K. Ebube et al., Pharm. Dev. Technol. 2 (2) 161–170 (1997).

45. K. Tahara, K. Yamamoto, and T. Nishihata, J. Control. Release. 35 (1) 59–66 (1995).

46. N. Kavanagh and O.I. Corrigan, Int. J. Pharm. 279 (1-2) 141–152 (2004).

47. S.P. Panomsuk et al., Chem. Pharm. Bull. 44 (5) 1039–1042 (1996).

48. J.C. Bode and C. Bode, Alcohol Malnutrition and the Gastrointestinal Tract, in: Nutrition and Alcohol, R.R. Watson, B. Watzl, Eds. (CRC Press, Boca Raton, FL, 1992) pp. 403–428.

49. C. Bode, J.C. Bode, Alcohol. Health. Res. W. 21 (1) 76–83 (1997).

50. A.F. Brown, D.S. Jones, and A.D. Woolfson, supplement to J. Pharm. Pharmacol. 50 157 (1998).

51. D.S. Jones et al., presentation at the AAPS Annual Meeting and Exposition (Toronto, ON, Canada, 2002).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here